However, our use of clinical groups also had a number of inherent weaknesses: For example, we did not enrich the arthritis group for depression at baseline, which may underlie why we observed only a modest reduction in HADSd (~1.5 points or 24%) following anti-TNF. Here, TNF is linked to arthritic joint disease.